1. What PEA actually is

PEA is a fatty acid amide your own body already produces. It sits in the family of molecules your cells make in response to physical stress, and it’s also present in ordinary food — eggs, peanuts, soybeans and milk all contain small amounts.

PEA, palmitoylethanolamide and palmidrol are the same compound. Palmitoylethanolamide is the chemical name. PEA is the abbreviation almost everyone uses. Palmidrol is the older pharmacological name you’ll still see in European papers and occasionally on a specialist’s note. You may also come across it written as “p e a” or “ultramicronized PEA”.

It was first isolated in the 1950s from egg yolk, and has been studied on and off ever since. In Australia it’s sold as a nutritional supplement, not a prescription medicine — which is why you’ll find it in compounding pharmacies and online rather than behind the dispensary counter.

2. How it works in the body

PEA is what researchers call an endogenous signalling molecule. Its best-described action is on a cell receptor called PPAR-alpha, which influences how genes involved in the body’s normal inflammatory response are switched on and off.

It also appears to act indirectly on the endocannabinoid system, slowing the breakdown of the body’s own related compounds rather than binding to those receptors itself. And it modulates mast cells and glial cells — the cells that amplify signalling in tissue and in nerves.

More than 600 papers on palmitoylethanolamide are indexed in the medical literature. That figure is a measure of how much research exists, not a claim about what it will do for any one person. Three representative papers:

• Micronised PEA in chronic pain — pooled analysis of clinical trials
• PEA and the endocannabinoid system: mechanism review
• Safety and tolerability of palmitoylethanolamide — systematic review

3. What people take it for

Two different questions get mixed together here, so it’s worth separating them: what published research has examined, and what our customers tell us they use it for. Neither is a promise of a result, and PEA is not a replacement for care you’re already receiving.

Areas the research has looked at

• Lower back pain — Studied in trials of sciatic and lumbar discomfort.
• Nerve pain — The largest body of published PEA research sits here.
• Fibromyalgia — Investigated alongside standard care, not in place of it.
• Osteoarthritis — Joint comfort and mobility measured over 8–12 weeks.
• Migraine — Smaller studies, mostly in younger participants.
• Pelvic discomfort — A modest but consistent research thread.

What customers most often mention when they write to us is mundane and specific rather than dramatic: getting going in the morning, sitting through a car trip, sleeping without shifting position all night. Most say it took between four and eight weeks of consistent daily use before they noticed anything at all, and some say they noticed nothing.

If you’ve been referred to PEA by a specialist or pharmacist, take their guidance on dose and duration over anything you read online, including this page.

4. Dose, and why micronisation matters

You’ll see PEA sold at 300mg, 400mg and 600mg. The number that matters is milligrams per serve, and the reference point in most published trials is 600mg daily — often taken as 300mg twice a day, or as two capsules together.

But the dose on the label is only half the story, because PEA is poorly soluble in water. In ordinary powder form, a large share of what you swallow can pass through without ever being absorbed.

Micronisation mills the raw material into far smaller particles, which increases the surface area available for absorption. Ultra-micronised is the finer grade again, and it’s the form used in most of the clinical work. A 600mg standard-powder capsule and a 600mg ultra-micronised capsule are not equivalent products, even though the front of the label reads the same.

Our formula is ultra-micronised PEA at 600mg per serve, with Quercetin 150mg and Luteolin 30mg — two flavonoids that appear alongside PEA in the research literature.

5. How to read a PEA label

If you’re comparing what’s on a chemist shelf against what’s online, five things separate the products. Check them in this order.

6. Safety, side effects and who shouldn’t take it

Published reviews of PEA report a tolerability profile broadly similar to placebo across trials, with no serious adverse events attributed to it. The effects most commonly reported are mild and digestive: some stomach upset, occasionally nausea, usually early on and usually passing.

That is not the same as “safe for everyone”. Speak with your doctor or pharmacist before starting if you are pregnant or breastfeeding, taking prescription medicines, managing a diagnosed condition, or giving it to anyone under 18. If you experience anything unexpected, stop taking it and get advice.

7. What customers report

Customer comments reflect individual experience and are not typical results. Reviews are edited for length.